Page last updated: 2024-10-27

gabexate and Asystole

gabexate has been researched along with Asystole in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luh, SP1
Tsai, CC1
Shau, WY1
Chen, JS1
Kuo, SH1
Lin-Shiau, SY1
Lee, YC1
Takemoto, Y1
Tanaka, S1
Tanabe, J1
Nakamura, Y1
Kohama, A1
Shibata, S1

Other Studies

2 other studies available for gabexate and Asystole

ArticleYear
The effects of inhaled nitric oxide, gabexate mesilate, and retrograde flush in the lung graft from non-heart beating minipig donors.
    Transplantation, 2000, May-27, Volume: 69, Issue:10

    Topics: Administration, Inhalation; Animals; Blood Pressure; Gabexate; Heart Arrest; Heart Rate; Hemodynamic

2000
Studies on the effects of primary therapy for DIC following circulatory arrest.
    American journal of hematology, 1986, Volume: 21, Issue:4

    Topics: Animals; Anticoagulants; Benzamidines; Blood Coagulation Tests; Disseminated Intravascular Coagulati

1986